The European Commission announced that the European Union has signed a new contract with Pfizer/BioNTech to purchase 1.8 billion doses of covid-19 vaccine from 2021 to 2023 to cover inventory, donation and resale doses.
The head of the EC, Ursula von der Leyen, wrote on Twitter: “I’m happy to announce that @EU_Commission has just approved a contract with @BioNTech_Group and @Pfizer for 900 million doses (possibly + 900 million doses) guaranteed,”
She announced: “Other contracts and other vaccine technologies will follow.”
The European Commission announced earlier this week that by July, there will be enough vaccines to satisfy 70% of the EU’s adult population.
In the second quarter, EU member states should receive a total of about 410 million doses, of which Pfizer/BioNTech has the largest number of 250 million doses, AstraZeneca 70 million doses, Johnson & Johnson 55 million doses and Moderna 35 million doses.